CORRECTING and REPLACING Webcast Alert: GeoPharma Inc. First Quarter 2009 Earnings Conference Call
31 Julio 2008 - 2:44PM
Business Wire
Contact phone number should read: Alexander Nachman, 727-471-0850,
ext. 243 (sted Alexander Nachman, 727-471-0871, ext. 243). The
corrected release reads: WEBCAST ALERT: GEOPHARMA INC. FIRST
QUARTER 2009 EARNINGS CONFERENCE CALL GeoPharma Inc. (Nasdaq: GORX)
announces the following Webcast: What: � Fiscal Year 2009 First
Quarter Earnings Release and Conference Call Earnings will be
released after the close on 8/14/08 Conference Call to follow. �
When: August 14, 2008 @ 4:35 PM Eastern � Where:
http://www.investorcalendar.com/ClientPage.asp?ID=132430 � How:
Live over the Internet � Simply log on to the web at the address
above. Live Dial-in (Toll Free): 877-407-8031 International
Dial-in: 201-689-8031 Teleconference Replay Available Until: August
28, 2008 @ 11:59 PM Replay Number (Toll Free): 877-660-6853 Replay
Number (International): 201-612-7415 Replay Pass codes (both
required for playback): Account #: 286 Conference ID #: 292766 �
For additional information, contact: Alexander Nachman,
727-471-0850, ext. 243 E-mail: ir@geopharmainc.com If you are
unable to participate during the live webcast, the call will be
available for replay at
http://www.investorcalendar.com/ClientPage.asp?ID=132430 or
http://www.investorcalendar.com GeoPharma, Inc. is a rapidly
growing Bio/Pharma company with a diversified business model
participating in 3 main market segments: Specialty Pharma,
Manufacturing, and Distribution. The Specialty Pharma division
specializes in the formulation of generic drugs for human and
veterinary usage and the development of medical devices used by
oncologists and other medical professionals. The Manufacturing and
Distribution divisions manufacture, package, and distribute generic
drugs, nutraceuticals, cosmetics, and functional food products for
companies worldwide. GeoPharma's growth strategy is to capitalize
on its research and manufacturing expertise to develop medical
devices and high margin generic drug products for niche markets
with high barriers to entry. GeoPharma's competitive advantage in
these areas is in its ability to navigate the challenges that such
market pursuits present effectively. Currently GeoPharma employs
over 300 people and operates facilities in Florida, Maryland,
Pennsylvania, Nevada, Rhode Island, and Texas utilizing over
330,000 sq. ft. of office, warehouse, manufacturing and laboratory
facilities. For further information visit the "For Investors"
section of the GeoPharma website at www.geopharmainc.com.
Geopharma (NASDAQ:GORX)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Geopharma (NASDAQ:GORX)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024
Real-Time news about Geopharma (MM) (NASDAQ): 0 recent articles
Más de GeoPharma Inc. Artículos de Noticias